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PREFACE 
 Recovering from a substance use disorder is challenging, and there are fewer 
environments more challenging than a college campus. Since the late 70s and early 80s 
college campuses have been experimenting with programs to build communities of support 
for students in recovery from addiction, but growth has been slow and haphazard. Similarly, 
slow and haphazard growth among recovery community organizations and other peer-based 
recovery support services have begun to build a backbone of recovery infrastructure across 
the country. Many factors contribute to stymied growth of these promising programs, but 
chief among them is the patchy evidence base for the efficacy and efficiency of these 
programs. This thesis represents an attempt to begin to fill one such gap, and to provide an 
additional tool for advocates and decision-makers, as well as those seeking guidance on how 
to improve efficiency in existing programs.   
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The prevalence of substance use disorders (SUDs) is greater among full-time college 
students and young adults regardless of enrollment status than it is among any other age 
group (1,2). These disorders represent substantial costs to both society and to institutions of 
higher education, both in terms of life years lost and in lost tuition revenue. The recent 
proliferation of collegiate recovery programs (CRPs) – supportive communities and resource 
centers for students seeking to maintain SUD recovery while pursuing a higher education – 
have the potential to help ameliorate some of these costs. While these CRPs are typically 
low-cost compared to acute care, a cost-effectiveness analysis of these programs has not yet 
been undertaken. In a comprehensive cost-effectiveness analysis, these programs were found 
to be cost-effective by the standards of the cost-effectiveness reference case from the societal 
perspective, and in line with the cost-effectiveness of other college health and wellness 
programs from the institutional perspective (3,4). In addition to being cost-effective, CRPs 
represent a cost savings to society and institutions across a wide range of variation.  
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BACKGROUND 
Literature Review  
Prevalence of Substance Use Disorder Among College Students  
 Substance use disorder (SUD) represents a pressing public health concern, with an 
estimated 19.7 million Americans (7.2% of the population) affected (2). The prevalence of 
this condition is higher among young adults (18 to 25 years old) than in any other age group, 
with young adult prevalence at 15.1%, nearly double the national prevalence (7.5%), more 
than double the prevalence among adults over 26 (6.6%), and more than triple the prevalence 
among adolescents (4.4%) (5). The 5.2 million young adults with a SUD represent 25.8% of 
the total population of individuals with SUD (2).  
In the US, 45,296 died in 2016 as a direct result of SUD (6). Those lives lost 
translated to 1,872,646 years of life lost, and over 4.8 million disability adjusted life years in 
2016 (6). The overall costs to society of SUD are $442 billion annually (7–9). In addition to 
the substantial toll of SUD, drug overdose fatalities rose to a record high of 70,237 in 2017, 
largely driven by the continuation of the opioid public health emergency (10). SUD is 
particularly prevalent among American Indian or Alaska Native populations (12.8%) and 
those who identify as belonging to two or more races (9.7%), while the greatest number of 
SUD cases are among non-Hispanic Whites at 13.1 million (1). 
  Over half of American adults (58.9%) have attended some college or more (11), and 
many (40.5%) young adults are enrolled in college every year (12). The college environment 
can be particularly challenging for those who struggle with substances, especially for those 
who meet the criteria for SUD. Among 18 to 22-year old undergraduate students who were 
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enrolled full time in college, 14.7% met the criteria for substance use disorder in 2016 (13). 
Prevalence was slightly higher among 18 to 22 year old young adults who were not enrolled 
in college at 15.1% (13).  
Of particular concern is the gap between perceived substance use and actual 
substance use among college-aged peers. Undergraduates believe that over 93% of their 
peers drank alcohol in the last 30 days, when in reality only 58.9% did (14). This disparity 
was even more pronounced for marijuana use: undergraduates believed that 83.5% of their 
peers consumed marijuana in the past 30 days, but only 18.1% did (14). This disparity 
between perceived substance use patterns and actual substance use patterns can lead a college 
student struggling with SUD to resist seeking help, to normalize problematic substance use, 
or to experience feelings of isolation when pursuing recovery (15). When only 7.2% of 
young adults who need SUD treatment receive it (16), removing some of the barriers to 
seeking and receiving help is essential, and there is high potential to reach these individuals 
on college campuses. 
Collegiate Recovery Programs 
Collegiate recovery programs (CRPs) developed to aid college students in or seeking 
recovery from SUDs by providing social support and access to recovery-supportive 
resources. These programs are housed on college campuses, typically as part of health or 
counseling services, or within student affairs divisions (17). CRPs consist of four 
components: a community of students in recovery from addiction, recovery-supportive 
programming (e.g. peer support meetings, sober social activities, service work), and a 
dedicated space supported by dedicated staff, which is often limited to one or two full-time 
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employees (18,19). Process evaluation studies of CRPs have found a variety of practices, 
including core functional activities that fall into the four key components described above, as 
well as additional practices that reflect campus cultural variation (17).  
Outcome evaluation studies demonstrate that students currently in CRPs experience 
lower relapse rates (8%) than the general population in SUD recovery (40-60%), and the 
lower relapse rates are preserved among alumni of these programs (10.2%), as well (20–22). 
In addition to their core function of supporting individual students in recovery, these 
programs typically serve as educational resources, as well, aiming to shift the norms around 
substance use on college campuses, potentially easing barriers to help-seeking for young 
adults struggling with SUDs (18,23).  
 While CRPs have existed since the late 1970s, the recent rapid growth of the field 
from approximately 29 programs in 2012 to over 184 programs in 2018 has resulted in a 
significant gap between the popularity and proliferation of these programs, and the evidence 
of their support, though what evidence exists is promising (17,18,20,21). The literature on 
CRPs represents only part of the evaluation hierarchy. The evaluation hierarchy is a 
framework for understanding the critical components necessary to plan, implement and 
assess effective programs, with needs assessment forming the bottom tier, followed by an 
assessment of program design and theory, program process and implementation, and program 
outcome or impact (24). An assessment of program cost and efficiency forms the final tier of 
the evaluation hierarchy (24). To date no efficiency evaluations of CRPs have been 
conducted. Efficiency evaluations are critical for both policymakers and higher education 
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administrators to decide whether these programs are a sound investment for their state or 
institution. 
 It is expected that these programs will be cost-effective, even when future benefits are 
discounted to account for the young age of the target population, because CRPs can be 
operated relatively inexpensively (19). The production function of CRPs is to facilitate peer 
support, and thus many of the most critical functions – peer support meetings, sober social 
activities, etc. – are driven by the students in recovery, themselves. Other peer support-based 
programs, such as Texas’ Peer Recovery Support Services demonstration project, have 
provided extensive cost savings by reducing hospitalizations, involuntary admissions and 
readmissions for individuals with either SUDs, mental health conditions, or both (25,26). It is 
expected that CRPs will prove to be similarly cost-effective and lead to substantial savings 
both for society and institutions of higher education.  
Public Health Significance 
Treatment of SUDs is costly. Each treatment episode is estimated to cost between 
$15,227 and  $22,436 in 2006 and 2010 dollars adjusted for inflation (27–29). Over 63% of 
individuals admitted for substance use disorder treatment in 2015 had at least one previous 
treatment episode, and 15.5% had five or more previous treatment episodes, thus it is 
critically important to improve recovery support and relapse prevention infrastructure to 
reduce the amount of repeat treatment episodes (30).  
Relapse rates for the general SUD population are between 40% to 60%, which is 
comparable to other chronic diseases such as type 1 diabetes (30% - 50%) and hypertension 
or asthma (50% - 70%), though this relapse rate does not account for those who may return to 
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substance use, but at levels that do not meet the criteria for SUD (22). Relapse rates among 
CRP participants are much lower, in contrast, at only 8% on average (range 0% - 25%), and 
these lower rates are maintained among program alumni (20,21). The protective effects of 
participating in peer-based recovery support in a naturalistic, community setting has also 
been observed in peer recovery support services and for adolescents in recovery high schools, 
thus there are multiple lines of evidence – some emerging, some well-established – 
supporting the efficacy of peer-based recovery support services delivered in a variety of 
settings (25,31). With treatment costs continuing to rise, a rise in mortality risk upon relapse 
due to the infiltration of powerful synthetic opioids into street drugs, it is particularly 
important to provide cost-effective recovery support resources in the communities and 
institutions where people in recovery may be most challenged (32). Due to outsized 
perceptions of substance use prevalence on college campuses described above, college 
campuses may be among the most challenging environments for people in recovery from 
SUD, as well as one of the most important opportunities for early intervention and secondary 
prevention due to the generally young age of college populations (14).  
Much of the existing literature on CRPs are descriptive studies or outcome evaluation 
studies, and may use traditional SUD outcome metrics such as relapse rates, comparable 
college health statistics, or recovery capital (20,21,33,34). To date, no efficiency evaluation 
studies of CRPs exist in the published literature, thus a cost-effectiveness analysis is needed 
to provide context to the promising health outcomes described in other studies.  
The threshold for cost-effectiveness from the societal perspective is by convention set 
at $50,000 per quality-adjusted life year (QALY) added by the intervention in question, but 
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the origins and continued utility of this threshold is in question (35,36). Current 
recommendations from the Second Panel on Cost-Effectiveness in Health and Medicine call 
for thresholds to be tied to comparable treatments that can best be understood by decision-
makers (4). In this case, the threshold for comparison can be set at treatment as usual (TAU), 
or the cost of additional treatment episodes, wherein college students attend treatment off-
campus and do not participate in a CRP. It may also be useful to compare the cost-
effectiveness of CRPs to the cost-effectiveness of other college health programs for the 
institutional perspective. For example, the cost-effectiveness of Hepatitis A/B vaccinations 
for college students is considered cost-effective at $8,500 per QALY (37). From the 
institutional perspective, the cost per student retained who would otherwise have been lost to 
substance-use related attrition is the effect or outcome of interest, rather than QALY.  
Objectives 
The purpose of this study is to determine whether CRPs meet the criteria for cost-
effectiveness described above. A secondary objective of this study is to design and 
disseminate a Cost-Effectiveness Toolkit for CRPs based on this comprehensive analysis that 
will allow advocates to conduct their own basic cost-effectiveness analysis of an existing or 
proposed CRP.    
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METHODS 
The reference case described by the First and Second Panel on Cost-Effectiveness in 
Health and Medicine provide a standard framework and methodology for conducting cost-
effectiveness analyses from the perspective of society and the healthcare system (3,4). For 
the cost-effectiveness analysis of CRPs from the societal perspective, the analysis will follow 
the reference case guidelines; however, some adjustments must be made for the analysis from 
the institutional perspective. 
Study Design 
Cost-effectiveness analysis involves the calculation of an intervention’s costs per unit 
of desired health outcome gained. The cost under a TAU scenario is subtracted from the cost 
under the intervention condition, in this case the cost of providing a CRP at an institution of 
higher education (3). This net cost is then divided by units of desired health outcome gained 
by the intervention, or the intervention’s effect (3). This general cost-effectiveness formula is 
presented in figure 1.  
 
Figure 1. The general cost-effectiveness formula.  !"#$	"&	'($)*+)($,"( − !"#$	"&	.*)/$0)($	/#	1#2/3'($)*+)($,"(	4&&)5$ − .*)/$0)($	/#	1#2/3	4&&)5$  
 
 
In the case of a traditional cost-effectiveness analysis from the societal perspective, 
the desired health outcome is quality-adjusted life years (QALYs) gained, which are used in 
this study as the outcome of interest for the societal perspective model (3). The Second Panel 
on Cost-Effectiveness recommends examining cost-effectiveness from both the perspective 
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of society and from the perspective of the healthcare system (4). Here, college and university 
campuses are substituted for the healthcare system perspective, as the burden of adopting 
CRPs as an intervention lies with these institutions. From this institutional perspective, the 
outcome of interest selected is the number of students retained who would otherwise be lost 
to substance use-related attrition. The costs to key campus resources and tuition lost to 
substance-related attrition represent the costs under the TAU scenario. Univariate and 
multivariate sensitivity analyses were conducted to account for uncertainty in both the 
societal and institutional perspective models (3).  
Study Setting 
Data on costs associated with CRPs were gathered from two national surveys of CRP 
staff and administrators conducted in 2015 and 2017, and used with permission of the authors 
(17,19). Of the 54 schools involved in the study by Jones and colleagues, 53 were located 
within a 4-year college or university, while one was categorized as a 2-year junior or 
community college (19). Most (81.5%) of the schools were public universities, while the rest 
(18.5%) were private (19). The Transforming Youth Recovery survey identified 184 
institutions offering a CRP; however, data on type of college or university (e.g. public, 
private, 2-year, 4-year) were not collected (17).  
Both surveys were cross-sectional in nature, and relied on self-reporting from CRP 
staff (17,19). Validity and reliability analyses were not reported for either survey instrument. 
The survey conducted by Jones and colleagues was limited to institutional members of the 
Association of Recovery in Higher Education, the national professional organization for 
CRPs, while the Transforming Youth Recovery survey was administered to the 
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organization’s grantees, recipients of technical assistance, and others identified as potentially 
having recovery support on campus (17,19).   
 Outcomes data on CRPs were drawn from a national cross-sectional study of CRP 
student participants (n = 486, programs represented = 29) conducted in 2012 by Laudet and 
colleagues, which reports average relapse rates along with relapse rate ranges for responding 
programs (20). Additional data sources for both the societal and institutional perspectives 
were drawn from the existing literature and are described below, and in tables 1 and 2. 
Data Collection 
Estimating Costs 
From the societal perspective, the total cost to society of SUD was found in the 
Surgeon General’s Report on Alcohol, Drugs, and Health, and is estimated to be $442 billion 
(7–9). To capture only the portion of societal costs attributable to college students with SUD,  
 
Table 1. Variables for the CRP CEA societal perspective model.  
Variable Description Source 
C The portion of the total financial cost to society of SUD 
attributable to full-time undergraduate college students aged 
18-22. 
(1,7–9) 
Ci Cost of SUD per individual in the target population.  (1,7–9) 
B CRP budget  (19) 
M Mean CRP membership (17) 
R Percent of students who experience a relapse. (20) 
Y Number of years of quality-adjusted life expectancy in either 
the TAU or CRP condition.  
(6,38) 
 
the total societal cost was multiplied by the proportion of the total SUD population that 
college students represent, which is approximately 0.052 (1). Thus, the total cost to society of 
 
 
10 
 
SUD among college students in one year is estimated to be $23,019,898,477.16, which 
represents the TAU condition. The per-person cost of college student SUD (variable Ci was 
found by dividing the cost of college student SUD by the number of college students with 
SUD, and was $22,436.55 per student. The formula for estimating the cost of TAU from the 
societal perspective is shown in figure 2.  
 
Figure 2. The cost of TAU from the societal perspective.  
! = ."$/3	!"#$	$"	7"5,)$8 ∗ :20;)*	"&	5"33)<)	#$2=)($#	>,$ℎ	71@:20;)*	"&	A0)*,5/(#	>,$ℎ	71@  
 
Estimating costs for the societal perspective intervention condition involves several 
assumptions. First, that a student who is participating in a CRP is not adding to the total 
societal costs, thus the per-person cost of SUD attributable to that student must be subtracted 
from the total cost to society. The second assumption is that only direct costs will be of 
interest to stakeholders, thus opportunity costs that CRP participants might incur will not be 
included in the model. The only direct cost to consider in this case is the CRP’s budget. CRP 
budgets were estimated from the Jones and Eisenhart data set (19). Twenty CRPs provided 
sufficient information about staff salaries and the proportion of the overall budget that 
salaries represented in order to solve for an estimated total budget for the CRP (19). Thus, 
intervention costs are the total costs to society with the savings attributed to CRP participants 
subtracted, plus the average estimated budget for a CRP. The estimated number of CRP 
participants is adjusted to account for the average 8% relapse rate (20). Mean membership 
size for CRPs were estimated from a survey of 124 CRPs (17). Respondents reported 
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membership size categorically, and true membership sizes were either interval censored (“6 
to 10 members”) or right censored (“51+ members”), and thus the true mean of membership 
sizes cannot be known from this dataset. To obtain an estimated mean for use in the base case 
models, the right-censored category was converted to an interval (“51 to 60 members”) and 
the midpoint of each interval was used to calculate a mean. The converted right-censored 
category is an overly conservative estimate: the largest CRPs serve as many as 100 students 
or more (39). While many CRPs also serve a vital function as health educators and resource 
brokers on their campuses, serving hundreds or thousands of students through education, 
training, or referrals, this CEA will be limited to accounting for their core function of 
recovery support. Figure 3 represents the estimated cost of the intervention condition. 
 
Figure 3. Estimated cost of the intervention condition.  ! − BC ∗ (1 − F)H + J 
 
 
From the institutional perspective, total costs include the cost of lost tuition revenue 
due to substance use-related attrition, and the opportunity costs of campus staff handling 
substance use-related cases. Substance use-related attrition is estimated to account for 
approximately 10% to 20% of general attrition, and 15% is used for the base model (40). The 
average general attrition rate is 24.7% (41). The average cost of annual tuition across all 
institutions is $26,120 (42). With an average undergraduate enrollment size of 4,551, the 
tuition revenue lost to substance-related attrition is just over $5.8 million at an average 
institution (43). Figure 4 presents the formula for estimating tuition lost to substance use-
related attrition. 
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Figure 4. Estimation of tuition lost to substance use-related attrition. . ∗ 4 ∗ K)()*/3	A$$*,$,"(	F/$) ∗ 72;#$/(5)	F)3/$)=	A$$*,$,"(	F/$) 
 
Opportunity costs for the institutional perspective are estimated by first finding the average 
hourly pay for three types of campus staff frequently responsible for handling substance-
related cases: student conduct officers (44), counselors (45), and campus law enforcement 
officers (46). Drug and alcohol-related incidents occurring on college campuses must be 
tracked and reported in a biennial review as required by the Drug-Free Schools and 
Communities Act (47). These incidents include both referrals to student conduct officers for 
drug and alcohol-related offenses, as well as on-campus arrests involving substances (43). To 
find the number of referrals and arrests attributable to a particular school, the proportion of 
the college population that the school represents is found by dividing the number of students 
at the school by the total number of undergraduate college students enrolled in a given year. 
This proportion is then multiplied by the number of referrals and arrests to find the 
approximate number attributable to the school. To find the total opportunity costs for student 
conduct referrals and arrests, the estimated number of cases is multiplied by the average 
hourly wage for student conduct officers and campus police officers. This approach likely 
underestimates opportunity costs, as it assumes only one hour of a staff person’s time per 
case. Figure 5 presents the formula for estimating opportunity costs associated with arrests 
and student conduct incidents related to substance use. 
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Table 2. Variables for the CRP CEA institutional perspective model.  
Variable Name Description Source 
A 
 
As 
 
 
Ag 
Attrition 
 
Attrition rate 
(substance-
related) 
Attrition rate 
(general) 
Tuition lost to substance-related attrition 
annually. 
Rate of substance-related attrition. 
 
 
Rate of general attrition. 
(40,41) 
 
Os Opportunity 
cost – Student 
Conduct 
The opportunity cost of Student Conduct staff 
working cases attributed to substance use. 
(43,44) 
Oc Opportunity 
cost – 
counseling 
services 
The opportunity cost of counseling center staff 
seeing patients for substance use-related 
sessions. 
(48,49) 
Oa Opportunity 
cost – arrests 
The opportunity cost of law enforcement for 
substance-related arrests on campus. 
(43,46) 
Ss,c,a Per-student 
opportunity 
cost 
Per-student opportunity cost for each type of 
opportunity cost described above. 
See above 
E Enrollment Undergraduate enrollment. (43) 
T Tuition Cost of tuition for 1 year. (42) 
 
Figure 5. Estimation of opportunity costs associated with arrests and student conduct 
incidents involving substance use.  
LM,O = 	7$/&&	P/<) ∗ (."$/3	:20;)*	"&	'(5,=)($# ∗ 4(*"330)($	7,Q)."$/3	#	!"33)<)	7$2=)($#	) 
The method for calculating the opportunity costs for counselors is different because 
substance-related counseling appointments are not required to be tracked under the Drug-
Free Schools and Communities Act. First, the average percent of the student body served by 
the counseling center was identified as 12%, though the range of variation is wide (1%  to 
74%) (48). Next, the prevalence of substance-related problems among students presenting to 
the counseling center for treatment was found (11%), as well as the average number of 
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sessions per client, which was 5.5 (49). Thus, the number of counseling sessions attributable 
to substance use disorder is a function of the enrollment size, and this number of sessions is 
multiplied by the average hourly wage for counselors. This is also likely to be an 
underestimate, as the costs captured here represent only the time spent in session with the 
student and does not capture time spent on associated paperwork or case management. Figure 
6 presents the estimation of opportunity costs associated with counseling for students with 
substance-related problems.  
 
Figure 6. Estimation of opportunity costs for students seeking counseling services for 
substance-related problems.  LS = 4 ∗ %	7$2=)($#	7)*+)= ∗ %	72;#$/(5)	1#)	!/#)# ∗ #	7)##,"(# 
 
 To estimate the cost of TAU, the total opportunity costs are added to the cost of 
substance-related attrition. To estimate the cost of the intervention condition, the cost 
attributable to each student who is participating in the CRP and is assumed to not be adding 
to these lost tuition costs or opportunity costs, is subtracted from the cost of TAU, and 
adjusted to account for relapse. The cost of the CRP budget is also included in the cost of the 
intervention condition. Figure 7 represents the estimation of the cost of TAU and the cost of 
the intervention condition from the institutional perspective. 
Estimating Effect 
 For the societal model, the outcome of interest, or effect for which the cost is being 
calculated, is the QALY (3,4). Measuring SUD-related quality of life is challenging, and may 
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vary widely depending on the type of drug an individual primarily consumes, their 
socioeconomic status, co-occurring mental or physical health conditions, and other 
 
Figure 7. Institutional model cost of TAU and cost of intervention condition. .A1 = A + LS + LM + LO '($)*+)($,"( = J + .A1 − B(C ∗ 1 − F) ∗ .H −U7M,S,O ∗ C ∗ (1 − F) 
 
demographic and life history factors, but more comprehensive measures of recovery capital 
do not directly translate into life years (6,50–53). Here, disability weights for different kinds 
of SUD (e.g. alcohol use disorder, opioid use disorder, etc.) from the Global Burden of 
Disease study were averaged for an aggregate SUD disability weight (6). Disability weights 
are effectively the inverse of a quality of life adjustment, and may be converted to use for the 
calculation of QALYs by subtracting the disability weight from 1 (54). The average quality 
of life adjustment was 0.586 (see table 3), but variable, with a range of 0.741 to 0.359 (6,54). 
The quality of life adjustment was then entered into Muennig’s quality-adjusted life 
expectancy calculator to find the new life expectancy for the two relevant age cohorts (ages 
15 to 19 and 20 to 24), and the difference between the SUD condition life expectancy and the 
good health condition life expectancy was averaged for the two groups (38). The average 
QALYs gained were 25.2 years.  
The institutional perspective is concerned with students retained who would 
otherwise have been lost to attrition as a measure of program effect. Part of the formula used 
to calculate the cost of substance-related attrition was used to calculate student attrition: the 
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Table 3. Health-related quality of life adjustments for substance use disorder, calculated from 
Whiteford et al., 2013.  
Condition Disability Weight CI QOL Adjustment 
AUD - Mild 0.259 (0.176-0.359) 0.741 
AUD - Moderate 0.388 (0.262-0.529) 0.612 
AUD – Severe 0.549 (0.384-0.708) 0.451 
Cannabis Dependence 0.329 (0.223-0.455) 0.671 
Cocaine Dependence 0.376 (0.235-0.553) 0.624 
Opioid Dependence 0.641 (0.459-0.803) 0.359 
Amphetamine 
Dependence 0.353 (0.215-0.525) 0.647 
Composite SUD Score 0.414  0.586 
 
total undergraduate enrollment size was multiplied by the general attrition rate, and again 
multiplied by percent of that attrition that is attributable to substance use, or about 15% 
(40,41). To estimate the number of students who would avoid being lost to substance-related 
attrition, the number of students who participate in the CRP multiplied by 1 minus the relapse 
rate are subtracted from the total number of students lost to substance-related attrition. Figure 
7 demonstrates how the effect was estimated for the institutional perspective.  
 
Figure 8. Formula for the estimation of intervention effect in the institutional perspective.  '($)*+)($,"(	4&&)5$ = #	7$2=)($#	V"#$ − (C ∗ (1 − F))	 
 
Data Analysis 
Societal Perspective  
 Each of the point estimates discussed above form the base case cost-effectiveness 
analysis. The value for each point estimate is provided in table 4. The incremental cost, or 
numerator, was found by subtracting the cost of TAU from the cost of the intervention from 
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the societal perspective. The incremental effect was found by subtracting the quality-adjusted 
life expectancy (QALE) in the TAU condition from the QALE in the intervention condition. 
To find the incremental cost effectiveness ratio (ICER) or cost per unit of health outcome, the 
incremental cost was divided by the incremental effect.  
 Each point estimate forming the base case model has some level of uncertainty. Due 
to the scarcity of data about CRPs, the CRP modeled from the data is particularly uncertain. 
To account for this uncertainty, and to understand which variables have the most impact on 
the model, two types of sensitivity analysis were conducted.  First, one-way sensitivity 
analyses were conducted in Excel by allowing one variable to vary over a plausible range of 
values while holding all other variables constant. The range of variation for each variable, as 
well as the source for that variation is detailed in Table 4. After identifying the influence 
each variable had over the model, critical thresholds of cost-effectiveness and cost savings 
were noted. The second type of sensitivity analysis conducted was a multi-way sensitivity 
analysis, in this case a Monte Carlo simulation. Each variable was allowed to vary within the 
parameters in Table 4, and an ICER was calculated for each of 10,000 iterations of variation. 
This allowed for the calculation of a new simulated ICER, along with a 95% confidence 
interval. A triangle distribution was assumed for each variable except CRP membership, 
which was assumed to be Poisson distributed. The Monte Carlo simulation was conducted in 
RStudio (55), and the code is included in Appendix B. 
The range of variation for each parameter was either determined from the literature or 
by adding or subtracting 20% from the base case parameter (see table 4). The incremental 
cost to society (Ci) range of variation is drawn from the literature, with the low estimate at 
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$15,227 and the base case at $22,436 (27,28). CRP budget variation was estimated by 
calculating the average budget for the top 50% most costly programs and the average for the 
bottom 50% (19). Early stage CRPs can be expected to have smaller membership sizes than  
 
Table 4. Parameters for sensitivity analyses of the societal model.  
Variable Base Case Low High Source 
C $23,019,898,477  $18,415,918,781 $27,623,878,172  +/- 20% 
Ci $22,436  $15,227 $22,436 (27,28) 
B $191,389.44  $159,399.47  $223,379.40  (19) 
M 14 8 19 (17) 
R 8% 0% 25% (20) 
Y* 0.586 0.359 0.741 (6,38) 
* Reported as quality of life adjustment used in the calculation of quality-adjusted life 
expectancy.  
 
programs that are more developed, so a mean for programs identified as early stage and a 
mean for programs identified as middle to late stage were calculated as the lower and upper 
bounds of variation, respectively. The reported relapse rate range is 0% - 25% (20). The 
variation in life years gained is bounded by the lowest quality of life adjustment in Table 3 
(“AUD – Mild”) and the highest (“Opioid Dependence”) (6). 
Institutional Perspective 
 Each point estimate used in the base case model was collected as described in the 
previous section (see table 2), and the value of each point estimate is provided in table 5. The 
incremental cost, or numerator, was found by subtracting the cost of TAU from the cost of 
the intervention condition. The incremental effect, or denominator, was found by subtracting 
the number of students lost to substance-related attrition in the intervention condition from 
the number of students lost in the TAU condition. Because this is expected to yield a 
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negative value, and the outcome of interest is a positive value (number of students retained 
who would have otherwise been lost to substance-related attrition), the observed value will 
be subtracted from the expected value. The value of the TAU condition should then equal 
zero, as the same number of students who are expected to be lost to attrition would be, and 
the estimation of the intervention condition will be a positive value. Figure 9 presents the 
formula used in the denominator to find incremental effect. The ICER was determined by 
dividing the incremental cost by the incremental effect to find the cost per unit of effect in 
the base case.  
 
Figure 9. Calculation of the incremental effect, or denominator, for the institutional model.  .A1 = B4 ∗ AM ∗ AWH − B4 ∗ AM ∗ AWH '($)*+)($,"( = B4 ∗ AM ∗ AWH − (B4 ∗ AM ∗ AWH − BC ∗ (1 − F)H) 
  
The methods for the one-way sensitivity analysis and the Monte Carlo simulation 
were the same for both the societal and institutional model. The parameters used in the 
sensitivity analyses for the institutional model are provided in table 5, and the code used for 
the Monte Carlo simulation in RStudio (55) is provided in Appendix B.  
Because the cost of substance-related attrition (variable A) is a function of the rate of 
substance-related attrition (variable As) and general attrition (variable Ag), only substance-
related attrition was varied in the sensitivity analyses. The range of 10% to 20% was 
provided as a plausible range in the original source material (40). Opportunity costs were 
varied by 20% rather than identifying plausible ranges of variation for each component of the 
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formula used to estimate these costs. No confidence interval or variance parameters were 
found for the hourly wages used in the calculation of opportunity costs, so these were also 
varied by 20%. The same procedure for establishing a plausible range of variation for the 
CRP-specific parameters (CRP budget, membership and relapse rate) was used in both the 
societal and the institutional model. An approximate range of variation from the literature 
was found for enrollment sizes and tuition costs and rounded to the nearest thousand 
(42,43,56,57). 
 
Table 5. Parameters for sensitivity analyses of the institutional model.  
Variable Base Case Low High Source 
A 
As 
$4,404,212.05 
15% 
$2,936,141.36 
10% 
$5,872,282.73  
20% 
(40) 
Os 
Oc 
Oa 
$1,078.41 
$8,393.03 
$272.85 
$862.73 
$6,714.43 
$218.28 
$1,294.10 
$10,071.64 
$327.41 
+/- 20% 
Ss 
Sc 
Sa 
$19.59 
$25.14 
$30.27 
$15.67 
$20.11 
$24.22 
$23.51 
$30.17 
$36.32 
+/- 20% 
B $191,389.44  $159,399.47  $223,379.40  (19) 
M 14 8 19 (17)  
R 8% 0% 25% (20) 
E 4,551 2,000 60,000 (43,56) 
T $26,120 $5,000 $50,000 (42,57) 
 
Toolkit 
 The Cost-Effectiveness Toolkit for Collegiate Recovery Programs (the Toolkit) was 
created in Excel using the methods described above for the base case calculations of 
incremental cost, incremental effect, and ICER. In the societal perspective model, users may 
enter their own data for an existing or proposed CRP, including CRP budget, membership 
size, and relapse rate. In the institutional model, users may enter CRP data as well as data 
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specific to their own institution. A worksheet for estimating institution-specific attrition costs 
(variable A), opportunity costs (variable Os,c,a) is included in the Toolkit. Users may also 
enter tuition costs and enrollment size specific to their institution. Appendix A provides 
additional details about using the Toolkit for custom estimations of ICER.  
Human Subjects  
This study is a secondary analysis of existing, de-identified data. No names of 
individuals or institutions will be included in any report or publication resulting from this 
study. This study was reviewed by the Committee for the Protection of Human Subjects at 
the University of Texas Health Science Center at Houston and was declared exempt 
according to 45 CFR 46.101(b). It was approved on December 6, 2018 (IRB number HSC-
SPH-18-1052).  
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JOURNAL ARTICLE 
Collegiate Recovery Programs are a Cost-Effective Tool to Address Substance Use 
Disorder in Young Adults - Addiction 
Introduction 
 Substance use disorder (SUD) affects a substantial portion of the population (7.2%), 
and is especially prevalent among undergraduate students aged 18 to 22 at 13.5% (1,2). 
These disorders are estimated to cost the US $442 billion annually, in part due to rising costs 
associated with treatment episodes (3–6). Further driving the costs to society are the lack of 
recovery support resources that help to reduce relapse and repeat treatment episodes. Most 
(63%) people have had more than one treatment episode and 15.5% had five or more 
treatment episodes (7). Collegiate recovery programs (CRPs) offer a potential amelioration to 
the tremendous costs to society both in terms of financial costs and lost life years, as students 
and alumni of these programs tend to experience much lower relapse rates than the general 
population in SUD recovery (8–10).  
 While CRPs are promising, little is known about the efficiency of these programs, as 
no economic evaluation of CRPs has yet entered the literature. This study represents the first 
such evaluation of CRP efficiency in the form of a comprehensive cost-effectiveness analysis 
from the societal perspective. This paper has a companion piece examining CRP cost-
effectiveness from the perspective of institutions of higher education (11,12). A secondary 
objective of this research was to create a toolkit for individual advocates and decision-makers 
to examine the cost-effectiveness of an existing or proposed CRP using user-supplied data.  
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Methods 
Cost-Effectiveness Analysis  
 Cost-effectiveness analysis involves the estimation of a cost per unit of desired health 
outcome as a measure of program efficiency (13,14). Costs are estimated for both the 
treatment as usual (TAU) and intervention (CRP) scenario, as are outcomes or effects. The 
incremental cost is found by subtracting the cost of TAU from the cost of the CRP scenario 
(13,14). The denominator of the ratio is the difference between the intervention effect and the 
TAU effect (13,14). In this case, the effect of interest is quality-adjusted life years added by 
CRPs compared to TAU. The incremental cost or numerator is divided by the incremental 
effect or denominator, resulting in an incremental cost-effectiveness ratio (ICER) (13,14).  
Estimating Costs 
 Total costs to society and costs per treatment episode were drawn from the literature 
(3,4,15). Only the portion of societal costs attributable to college students with SUD were 
captured in the model (1). Budgets for CRPs were estimated from a 2015 survey of CRP staff 
wherein 20 respondents provided sufficient information with which to estimate a total budget 
for the program (16). Membership sizes for CRPs were estimated from an interval-censored 
and right-censored data set, where mean values were used in place of intervals to calculate an 
approximate mean (17). Previous outcome evaluation research on CRPs indicate a low 
relapse rate (8%) and provide a measure of variance (8). Variables used to calculate cost are 
detailed in table 1, and table 2 provides a pointe estimate for each variable.  
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Estimating Effect 
 The outcome of interest is quality-adjusted life years (QALYs) gained by the 
intervention compared to TAU (13,14). Quality of life adjustments for calculating quality-
adjusted life expectancies vary widely depending on substance used and severity of the 
condition, thus an average figure was used (18). The average quality of life adjustment was 
calculated by first converting disability weights from Whiteford et al. to quality of life 
adjustments by subtracting from 1, and scores were averaged across all conditions (18,19). 
The resulting averaged SUD quality of life adjustment was entered into a life expectancy 
table to gain an average life expectancy across the two relevant age groups (15 to 19 and 20 
to 24) (20). The parameters used in the calculation of effect are detailed in table 1, and the 
point estimate used in the base case model is provided in table 2.  
Dealing with Uncertainty 
 Two types of sensitivity analysis were undertaken to explore uncertainty in the 
model. First, one-way sensitivity analyses allowed for the exploration of how each variable 
impacts the ICER when allowed to vary across a plausible range of variation, while holding 
all other variables constant. The second type of sensitivity analysis conducted was a Monte 
Carlo simulation to examine the impact of allowing all variables to vary simultaneously over 
10,000 simulated iterations. The resulting averaged ICER and 95% confidence interval 
provides an estimate that accounts for variation in all of the variables simultaneously. The 
parameters used for both types of sensitivity analysis are presented in table 2.  
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Results 
 The cost of operating a CRP in the base case is $97,586.24 less than the cost of 
treatment as usual and adds just over 25 QALYs. The incremental cost-effectiveness ratio 
(ICER) for the societal model in the base case is -$3,872.75, or a cost savings of $3,872.75 
per QALY gained when implementing a CRP (see Table 1). 
 The results of the one-way sensitivity analysis are presented in Figure 1 and Table 2. 
Throughout the range of variation of each of the parameters, except for CRP membership, the 
utilization of a CRP was always an overall cost savings. In the case of CRP membership, the 
intervention is not an overall cost savings at the lowest end of the range of variation (8 
members); however, it is still cost-effective in that it is both less expensive than an additional 
treatment episode, and less expensive than the commonly-used $50,000 benchmark for 
acceptable cost per QALY (5,6,21). When all other parameters in the base case are held 
constant, at least 10 CRP members are needed to constitute cost savings. CRP membership 
held the most influence over the model compared to other variables. One-way sensitivity 
analyses of effectiveness, in this case QALYs gained, were conducted but not included here. 
It is an established phenomenon that when numerators are negative, one-way sensitivity 
analyses of effectiveness do not produce expected results, in this case, as effectiveness 
increased the intervention appeared to become more expensive (22–24).  
 The Monte Carlo simulation resulted in a slightly lower predicted cost savings of -
$2,990.94 (95% CI; -$3,073.11, -$2,908.77) over 10,000 iterations.  
 
 
26 
 
Discussion  
Because the ICER is negative, caused by a negative numerator in the initial CEA 
calculation, there is some ambiguity to the interpretation of these results. When the cost of 
the new intervention being compared to treatment as usual represents an overall cost savings, 
the numerator will be negative, leading to a negative ICER. A negative ICER has been 
interpreted to mean that the intervention is an overall cost savings per unit of health outcome, 
but others argue that the interpretation is less straightforward (22–24). Further, measures of 
effectiveness in the denominator, in this case QALYs gained, cannot be subjected to a 
sensitivity analyses, as the results will be the inverse of what is expected (4-6).  
The more conservative estimate of ICER in the Monte Carlo simulation may be due 
to the use of triangle distribution for all simulated variables except CRP membership, which 
was assumed to be Poisson distributed. The triangle distribution may provide an overly 
cautious representation of the true range of variation among CRPs but must be used as the 
true distribution is unknown due to the limited number of studies that capture data about CRP 
operations.   
The primary limitation of this study is the limited availability of data about collegiate 
recovery programs. Due to the rapid growth in the field in recent years, data collection efforts 
have lagged behind need. The data set from which CRP budget information was gathered 
represents only 54 of the 184 currently operating CRPs, and only 20 of these respondents 
provided budgetary information (16,21). Relapse rates for CRPs are even more dated, 
collected in 2012 when only 29 CRPs were in operation (14). While these factors pose a 
limitation to the model CRP created for use in CEA here, this limitation does not apply to 
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collegiate recovery professionals and advocates who wish to substitute their own CRP’s data 
for the model CRP data used here. Interested advocates may do so by using the Cost-
Effectiveness Toolkit for CRPs (“the Toolkit”) at <<URL forthcoming>>.  
As healthcare costs continue to rise during a time when unprecedented numbers of 
Americans are struggling with opioids, it is essential to find cost-effective solutions to help 
prevent relapse among those who receive treatment. The wide range of variation in which 
CRPs represent a cost savings compared to treatment as usual is promising to the continued 
proliferation of these programs at colleges and universities across the country. A companion 
article presents the institutional perspective cost-effectiveness analysis of CRPs, and both 
perspectives demonstrate cost-effectiveness and cost savings (11). 
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Figures and Tables 
Table J1.1. Variables used in the societal perspective model. 
Variable Description Source 
C The portion of the total financial cost to society of SUD 
attributable to full-time undergraduate college students aged 
18-22. 
(1,3,4,15) 
Ci Cost of SUD per individual in the target population.  (1,3,4,15) 
B CRP budget  (16) 
M Mean CRP membership (17) 
R Percent of students who experience a relapse. (8) 
Y Number of years of quality-adjusted life expectancy in either 
the TAU or CRP condition.  
(18,20) 
 
Table J1.2. Parameters for sensitivity analyses of the societal model.  
Variable Base Case Low High Source 
C $23,019,898,477  $18,415,918,781 $27,623,878,172  +/- 20% 
Ci $22,436  $15,227 $22,436 (5,6) 
B $191,389.44  $159,399.47  $223,379.40  (16) 
M 14 8 19 (17) 
R 8% 0% 25% (8) 
Y* 0.586 0.359 0.741 (18,20) 
* Reported as quality of life adjustment used in the calculation of quality-adjusted life 
expectancy.  
 
Table J1.3. Cost-effectiveness table for the CEA of CRPs. 
Intervention Total Cost 
Total 
Effectiveness 
Incremental 
Cost 
Incremental 
Effectiveness ICER 
Treatment as 
Usual 
$23.02 
billion 35.66 QALE    
Collegiate 
Recovery 
Program 
$22.991 
billion 60.82 QALE 
 
-$97,593.31 25.2 QALE -$3872.75 
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Table J1.4. Results of the one-way sensitivity analysis of the societal model cost-
effectiveness analysis of CRPs. 
Variable Low High Additional Details 
TAU Cost Per 
Person  -$188.22  -$3,879.77 
For every $500 increase in the incremental 
cost of TAU, CRPs represent an additional 
$256 in cost savings per QALY gained. 
CRP Budget  -$2,608.22  -$5,151.89 
For every $1,000 additional in CRP budget, 
only $39 less in cost savings per QALY 
gained. 
CRP 
Membership  $1,043.89   -$7,983.33 
For every CRP member gained, $820 
increase in cost savings. 
Relapse Rate -$4,879.11 -$1,757.05 
For every 1% increase in relapse rate, $124 
reduction in cost savings.  
 
Figure J1.1. One-way sensitivity analysis of the societal model of CRP Cost-Effectiveness. 
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JOURNAL ARTICLE 
Cost-Effectiveness of Collegiate Recovery Programs from the Perspective of Colleges 
and Universities - Journal of American College Health 
Abstract 
 Objective: This cost-effectiveness analysis of collegiate recovery programs (CRPs) 
from the perspective of institutions of higher education was conducted to fill a critical gap in 
the evaluation research on CRPs. A companion article on the cost-effectiveness of CRPs 
from the societal perspective is forthcoming.1 Participants: Two existing data sets were used 
to construct a model CRP for analysis.2,3 These data represent 54 and 184 CRPs from across 
the US.2,3 Methods: A base model incremental cost-effectiveness ratio (ICER) was 
calculated to assess cost per student retained from substance-related attrition. One-way and 
multi-way (Monte Carlo simulation) sensitivity analyses explored uncertainty in the base 
model and identified critical thresholds. Results: CRPs represent an overall cost savings, 
with an ICER of -$11,230.93 per student retained. CRPs remain a cost-saving intervention 
across a wide range of plausible variation, including in the Monte Carlo simulation (ICER = -
$8,196.28; 95% CI -$8467.48, -$7925.08). Conclusions: In spite of the limitations imposed 
by data availability and uncertainty, CRPs are cost-effective and cost-saving across a wide 
range of variation.  
Keywords: Substance use disorder, recovery, collegiate recovery programs, cost-
effectiveness, efficiency evaluation.  
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Introduction 
 Collegiate recovery programs (CRPs) have a long history, with the first programs 
established in the 1970s and 1980s, but these programs did not proliferate widely until recent 
years.3 This recent growth in the field – from approximately 29 programs in 2012 to just over 
184 programs today – is in part due to increased attention paid to substance use disorders 
(SUD) among young adults in light of the national public health crisis related to opioids.3–5 
These programs can play a critical role in ensuring that costly interventions for SUD are less 
likely to result in a recurrence of use, given that participants in these programs are less likely 
to relapse than the general SUD population, and that this recovery protection carries on past 
graduation.5–7  
In spite of these promising outcomes, CRPs have not been as widely adopted or 
supported as may be expected. For example, a minority (39%) of currently operating CRPs 
report full institutionalization in the form of funding and inclusion in strategic planning 
within the larger university setting.3 One possible explanation for the slow diffusion of CPRs 
into the college health landscape are concerns regarding expense and efficiency. To date, no 
evaluation of the efficiency of a CRP has been published in the literature, representing a 
critical gap in the evaluation research on these programs.  
This study represents the first evaluation of CRP efficiency in the literature, using the 
method of cost-effectiveness analysis (CEA). This CEA of a CRP modeled from existing 
data sources is from the perspective of institutions of higher education, and thus reports 
findings in terms of students who have been retained instead of lost to substance use-related 
attrition. Substance use-related attrition is believed to represent between 10% and 20% of all 
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attrition cases among first-year students, though the model presented here accounts for 
uncertainty in this estimate.8 A companion article assessing cost-effectiveness of CRPs from 
the perspective of society, which measures the cost of a CRP per additional quality-adjusted 
life year (QALY) gained, is forthcoming.1 Those who wish to assess cost-effectiveness at 
their own CRP may do use by using the Cost-Effectiveness Toolkit for CRPs at <<URL 
forthcoming>>. 
Methods 
 Cost-effectiveness analysis is the method of assessing how much an intervention 
costs compared to the standard method of care, in terms of cost per unit of health outcome.9,10 
In this case, operating a CRP on a college campus is compared to not offering a CRP, but 
offering standard services such as counseling and student conduct case management. The 
cost of these services are captured as opportunity costs in the model. These costs are then 
divided by the desired health outcome achieved by the intervention, in this case students 
retained who would otherwise have been lost to substance-related attrition.  
The first layer of analysis is the single point estimate of the incremental cost-
effectiveness ratio (ICER), or the cost per student retained. The cost to institutions of not 
having a CRP was estimated by first calculating tuition dollars lost to substance-related 
attrition, and combining that with opportunity costs of campus staff who may interact with 
students in active SUD.8,11–16 The average number of undergraduate students per college 
campus and the median annual tuition across the US were used in the base model.11,17 
Average CRP budgets and participation sizes (also called membership) were calculated from 
two national surveys of these programs, and found to be approximately 14 students, though 
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there is wide variation between programs.2,3 Average relapse rates among CRP students 
(8%), as well as the range of variation in relapse rates (0% - 25%), were from the literature.5 
Table 1 details each of the variables in the institutional perspective model and provides a 
source for each. Table 2 details the point estimate for each variable.  
To account for uncertainty in model estimations, as well as to account for variation in 
program size, membership, relapse rates and other variables, two types of sensitivity analysis 
were conducted. First, one-way sensitivity analyses demonstrated the impact of each variable 
on the overall model and the resulting ICER, and allowed for the identification of critical 
thresholds of cost per unit of health outcome. Multi-way sensitivity analysis, in this case a 
Monte Carlo simulation, allows all variables to vary simultaneously within a given set of 
parameters. The 10,000-iteration Monte Carlo simulation was conducted in RStudio, and 
provided an estimation of the variance of the overall model.18,19 Triangle distributions are 
assumed for all variables in the Monte Carlo simulation, except CRP membership, which is 
assumed to be Poisson distributed. The parameters for each variable used in the sensitivity 
analyses are available in table 2.  
Results 
 In the base model of cost-effectiveness of a CRP from the perspective of the 
institution, the presence of a CRP saves the university $11,230.93 for each student retained 
who would otherwise have been lost to substance-related attrition (ICER = -$11,230.94). 
CRPs can be considered both cost-effective and an overall cost-savings. Table 3 presents the 
incremental cost, incremental effectiveness, and incremental cost-effectiveness ratio (ICER) 
of the base model.  
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 The results of the one-way sensitivity analyses are presented in Table 4 and visually 
represented in Figure 1. The underlying rate of attrition from a university, the rate of attrition 
attributable to substance use, and the number of undergraduate students enrolled in the 
institution have no impact on the overall model: the program is equally cost-effective no 
matter how these components vary. The per-student opportunity costs associated with college 
or university staff whose caseloads include students who struggle with substances had little 
impact on the model: for every 20% increase or decrease in per-student opportunity cost, 
there was a corresponding $15 change in ICER.   
 Variables that exerted greater influence on the model were the cost of tuition, CRP 
membership, the CRP budget, and the relapse rate for students participating in the CRP. For 
every $1,000 that the cost of annual tuition increases, the cost savings to the institution 
increase by $990.77. The relationship between CRP budget and ICER was also linear: for 
every additional $1,000 spent on a CRP budget, there was a $77.64 reduction in cost savings 
when all other variables were held constant. With all other variables constant including a 
membership of 14 students, a budget of $290,000 and above is no longer a cost savings, 
though may still be considered cost-effective depending on cost-per-student tolerance at an 
institution. The relationships of both CRP membership and relapse rate to ICER were non-
linear. Throughout the entire range of potential values of relapse rate (0% to 25%), the ICER 
remained negative representing an overall cost-savings.5  
 The mean ICER from the Monte Carlo simulation of 10,000 variations was -
$8,196.28 (95% CI -$8,467.48, -$7,925.08), representing less cost savings per student 
retained than the point estimate ICER from the base model. The uncertainty introduced by 
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the sparse data available for CRP parameters may contribute to the discrepancy between the 
Monte Carlo simulation and the base case point estimation.  
Comment 
 Throughout the plausible range of variation for almost all variables, CRPs represent a 
substantial cost savings to the institution per student. As CRP participation drops, the 
program becomes less cost-effective, though this effect can be mediated if the budget is 
appropriately matched to the size of the program in terms of student participants, for 
example, by maintaining appropriate staff to student ratios. Similarly, campuses with below 
average tuition costs may experience reduced cost savings, as much of the savings come in 
the form of avoiding lost tuition due to substance-related attrition. Because relapse rates also 
exert influence over the model, care should be taken to balance appropriate staff to student 
ratios with adequate resources to provide support and keep relapse rates low.  
CRPs are equally cost-saving across institutions of differing sizes and with differing 
rates of general or substance-related attrition. While variations in staff salaries may impact 
the per-student opportunity cost, this type of cost has little impact on the model. For 
institutions considering adding a CRP to their campus or deepening support for an existing 
CRP, it is critical to consider thresholds of participation and appropriately matched budgets, 
though the range of acceptable variation while still maintaining cost savings is wide.   
Limitations and Conclusion 
 A negative value for incremental cost and ICER, representing an overall cost savings, 
leads to some ambiguities in interpretation.20–22 The national benchmarking data available for 
CRPs is limited, and thus a major limitation to this evaluation is the uncertainty inherent in 
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the modeled CRP. In order to minimize uncertainty in the decision-making process, those 
who wish to explore the cost-effectiveness of a CRP at one’s own institution may use the 
Cost-Effectiveness Toolkit for CRPs available at <<URL forthcoming>> and substitute their 
own known data. The limitation of the sensitivity analyses is related to data availability, as 
well: the true range of variation and underlying probability distribution of that variation is not 
known, and thus the modeled variation presented here is likely to be overly conservative. In 
spite of these limitations, evidence for the efficiency of CRPs has now been added to the 
literature, complementing the evidence for the effectiveness of these programs.   
  
 
 
40 
 
References 
1.  Castedo S, Brown HS, Springer A, et al. Collegiate Recovery Programs are a Cost-
Effective Tool to Address Substance Use Disorder in Young Adults. Be Determined. In 
press. 
2.  Jones JA, Eisenhart E, Charles B, Walker N. Results of the 2015 National Collegiate 
Recovery Programs Profiles Study. Presented at the: Association of Recovery in Higher 
Education 7th Annual Conference; April 6, 2016; Atlanta, GA. 
3.  Transforming Youth Recovery. 2017 Census and Definitions for Recovery Support in 
Higher Education. Reno, NV: Transforming Youth Recovery; 2018. 
https://www.transformingyouthrecovery.org/wp-content/uploads/2018/03/2017-Census-
20180319.pdf. 
4.  Christie C, Baker C, Cooper R, Kennedy PJ, Madras B, Bondi P. The President’s 
Commission on Combating Drug Addiction and the Opioid Crisis. Washington, D.C.: 
The President’s Commission on Combatting Drug Addiction and the Opioid Crisis; 2017. 
5.  Laudet AB, Harris K, Kimball T, Winters KC, Moberg DP. Characteristics of Students 
Participating in Collegiate Recovery Programs: A National Survey. J Subst Abuse Treat. 
2015. doi:10.1016/j.jsat.2014.11.004 
6.  McLellan AT, Lewis DC, O’Brien CP, Kleber HD. Drug dependence, a chronic medical 
illness: implications for treatment, insurance, and outcomes evaluation. JAMA. 
2000;284(13):1689-1695. 
7.  Brown AM, Ashford RD, Figley N, Courson K, Curtis B, Kimball T. Alumni 
Characteristics of Collegiate Recovery Programs: A National Survey. Alcohol Treat Q. 
2018;0(0):1-14. doi:10.1080/07347324.2018.1437374 
8.  Everfi. Estimating Revenue Lost from Alcohol-Related Attrition. 
http://info.everfi.com/rs/410-YCZ-984/images/Calculator%20-%20Alcohol-
Related%20Attrition%20Lost%20Revenue.xlsx. 
9.  Sanders GD, Neumann PJ, Basu A, et al. Recommendations for Conduct, 
Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel 
on Cost-Effectiveness in Health and Medicine. JAMA. 2016;316(10):1093-1103. 
doi:10.1001/jama.2016.12195 
10.  Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the 
Panel on Cost-effectiveness in Health and Medicine. JAMA. 1996;276(15):1253-1258. 
11.  National Center for Education Statistics. Digest of Education Statistics, 2016. 
Washington, D.C.: Department of Education; 2018. 
 
 
41 
 
12.  Reetz DR, Bershad C, LeViness P, Whitlock M. The Association for University and 
College Counseling Center Directors Annual Survey.; 2016. 
https://www.aucccd.org/assets/documents/aucccd%202016%20monograph%20-
%20public.pdf. 
13.  Bureau of Labor Statistics, U.S. Department of Labor. Occupational Outlook Handbook, 
Police and Detectives. https://www.bls.gov/ooh/protective-service/police-and-
detectives.htm. Published 2018. Accessed January 20, 2019. 
14.  PayScale. Student Services Coordinator Salary | PayScale. 
https://www.payscale.com/research/US/Job=Student_Services_Coordinator/Salary. 
Published 2019. Accessed January 20, 2019. 
15.  Pritchard A, McChesney J. Focus on Student Affairs, 2018: Understanding Key 
Challenges Using CUPA-HR Data. College and University Professional Association for 
Human Resources; 2018:17. 
16.  LeViness P, Bershad C, Gorman K. The Association for University and College 
Counseling Center Directors Annual Survey. Association for University and College 
Counseling Center Directors; 2017:71. 
17.  Kowarski I. 10 Colleges With the Most Undergraduates. US News & World Report. 
https://www.usnews.com/education/best-colleges/the-short-list-college/articles/colleges-
with-the-most-undergraduates. Published 2018. Accessed January 27, 2019. 
18.  RStudio Team. RStudio: Integrated Development for R. Boston, MA: RStudio, Inc.; 
2016. http://www.rstudio.com/. 
19.  Castedo de Martell S. Cost-Effectiveness of Collegiate Recovery Programs. 2019. 
20.  Stinnett AA, Mullahy J. The Negative Side of Cost-effectiveness Analysis. JAMA. 
1997;277(24):1931-1932. doi:10.1001/jama.1997.03540480031025 
21.  Stinnett AA, Mullahy J. Net Health Benefits: A New Framework for the Analysis of 
Uncertaintly in Cost-Effectveness Analysis. Med Decis-Mak. 1998;18(2_suppl):S68-S80. 
22.  Fenwick E, Marshall DA, Levy AR, Nichol G. Using and interpreting cost-effectiveness 
acceptability curves: an example using data from a trial of management strategies for 
atrial fibrillation. BMC Health Serv Res. 2006;6:52. doi:10.1186/1472-6963-6-52 
23.  National Center for Education Statistics. Table 326.30. Retention of First-Time Degree-
Seeking Undergraduates at Degree-Granting Postsecondary Institutions, by Attendance 
Status, Level and Control of Institution, and Percentage of Applications Accepted: 
Selected Years, 2006 to 2016. Washington, D.C.: US Department of Education; 2017. 
 
 
42 
 
24.  U.S. Department of Education, National Center for Education Statistics. Fast Facts: 
Tuition costs of colleges and universities. https://nces.ed.gov/fastfacts/display.asp?id=76. 
Published 2018. Accessed January 29, 2019. 
25.  StepUP Program. Frequently Asked Questions. StepUP Program. 2016. 
http://www.augsburg.edu/stepup/frequently-asked-questions/. Accessed August 14, 2016. 
26.  National Center for Education Statistics. Table 303.10. Total fall enrollment in degree-
granting postsecondary institutions, by attendance status, sex of student, and control of 
institution: Selected years, 1947 through 2026. Digest of Education Statistics. 
https://nces.ed.gov/programs/digest/d16/tables/dt16_303.10.asp?current=yes. Published 
2016. 
27.  College Board. 2018-19 Tuition and Fees at Public Four-Year Institutions by State and 
Five-Year Percentage Change in In-State Tuition and Fees - Trends in Higher Education 
- The College Board. https://trends.collegeboard.org/college-pricing/figures-tables/2018-
19-state-tuition-and-fees-public-four-year-institutions-state-and-five-year-percentage. 
Published 2018. Accessed January 29, 2019. 
 
 
  
 
 
43 
 
Tables and Figures 
 
Table J2.1. Institutional model parameters and sources. 
Variable Name Description Source 
A 
 
As 
 
 
Ag 
Attrition 
 
Attrition rate 
(substance-
related) 
Attrition rate 
(general) 
Tuition lost to substance-related attrition 
annually. 
Rate of substance-related attrition. 
 
 
Rate of general attrition. 
8,23 
 
Os Opportunity 
cost – Student 
Conduct 
The opportunity cost of Student Conduct staff 
working cases attributed to substance use. 
11,14 
Oc Opportunity 
cost – 
counseling 
services 
The opportunity cost of counseling center staff 
seeing patients for substance use-related 
sessions. 
12,16 
Oa Opportunity 
cost – arrests 
The opportunity cost of law enforcement for 
substance-related arrests on campus. 
11,13 
Ss,c,a Per-student 
opportunity 
cost 
Per-student opportunity cost for each type of 
opportunity cost described above. 
See above 
E Enrollment Undergraduate enrollment. 11 
T Tuition Cost of tuition for 1 year. 24 
 
Table J2.2. Parameters for the base case and sensitivity analyses of the institutional model.  
Variable Base Case Low High Source 
A 
As 
$4,404,212.05 
15% 
$2,936,141.36 
10% 
$5,872,282.73  
20% 
8 
Os 
Oc 
Oa 
$1,078.41 
$8,393.03 
$272.85 
$862.73 
$6,714.43 
$218.28 
$1,294.10 
$10,071.64 
$327.41 
+/- 20% 
Ss 
Sc 
Sa 
$19.59 
$25.14 
$30.27 
$15.67 
$20.11 
$24.22 
$23.51 
$30.17 
$36.32 
+/- 20% 
B $191,389.44  $159,399.47  $223,379.40  2 
M 14 
14 
8 
1 
19 
100 
3 Monte Carlo 
3,25 One-Way 
R 8% 0% 25% 5 
E 4,551 2,000 60,000 11,26 
T $26,120 $5,000 $50,000 24,27 
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Table J2.3. Cost effectiveness table for collegiate recovery programs from the perspective of 
institutions of higher education. 
Intervention Total Cost 
Total 
Effect 
Incremental 
Cost 
Incremental 
Effectiveness ICER 
Absence of 
a CRP $4,413,656.92 0 N/A N/A N/A 
Presence of 
a Collegiate 
Recovery 
Program $4,267,654.79  13 
 
-$146,002.13 
13 students 
retained -$11,230.93 
 
 
 
Table J2.4. One-way sensitivity analysis of the cost-effectiveness of collegiate recovery 
programs: a description of the impact of each variable on the model.  
Variable Low High Additional Details 
Tuition 
$9,297.81 -$24,388.35 
As tuition increases, CRPs become a more 
cost saving alternative. For every $1,000 
increase in tuition, $990.77 increase in cost 
savings. When annual tuition and fees fall at 
or below $14,000, the intervention is not a 
cost savings when other variables are held 
constant.  
Per-Student 
Opportunity 
Cost -$11,320.57 -$11,350.57 
For every 20% increase in the per-student 
opportunity cost, the cost savings increase by 
$15, and the inverse is also true.  
CRP Budget 
-$13,819.26 -$8,851.88 
For every additional $1,000 spent on a CRP 
budget, there is a $77.64 decrease in cost 
savings per student retained.  
CRP 
Membership 
-$191.00 -$15,245.95 
Non-linear relationship between membership 
and ICER. The critical threshold below 
which the intervention is no longer a cost 
savings is 10 members, but still cost-effective 
above 2 members.  
Relapse 
Rate 
-$12,524.32 -$7,967.43 
Non-linear relationship between relapse rate 
and ICER. The critical threshold below 
which the intervention is no longer a cost 
savings is a relapse rate of 40%. The 
intervention remains cost-effective at or 
above a relapse rate of 81%. 
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Figure J2.1. One-way sensitivity analysis of the cost-effectiveness of collegiate recovery 
programs, presenting only variables that impact the model. 
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CONCLUSION 
From both the societal and institutional perspectives, CRPs are not only cost-
effective, but also cost-saving, even over a wide range of variation to account for relatively 
high amounts of uncertainty in the data. CRP membership size, CRP budget, and relapse rate 
impact the cost-savings and cost-effectiveness of CRPs compared to TAU in both the societal 
and institutional perspective models, thus it is important to ensure that CRP hiring practices 
and budget allocations are an appropriate fit for the membership size. Similarly, it is 
important to maintain adequate staff to student ratios and provide sufficient resources to CRP 
operations in order to keep relapse rates contained.  
The cost of TAU and tuition also impact the cost-effectiveness and cost savings 
provided by the intervention. When the cost of additional treatment episodes in the societal 
perspective model, or the cost of tuition in the institutional perspective model, becomes less 
expensive, then CRPs represent less of a cost savings and are less cost-effective; however, 
with both healthcare costs and tuition costs continuing to rise, it is unlikely that these costs 
will become so inexpensive as to become dominant relative to CRPs.  
Given the uncertainty in the data gathered, particularly in the data used to model a 
typical CRP, the Toolkit provides a tool for advocates seeking to reduce uncertainty by 
inputting their own data into the models. The primary limitation of this research was the 
availability of data on CRPs. Only 20 CRPs provided sufficient information from which to 
estimate a total budget, and CRP membership size was estimated from interval-censored and 
right-censored data (17,19). One strength of this research is that this uncertainty was 
explored in depth in two types of sensitivity analyses, and that the cost-effectiveness and 
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cost-savings found in the base model were retained throughout a wide range of variation. The 
greatest strength of this research is that it represents the first evaluation of CRP efficiency to 
enter the literature and may spur additional research into the economics of these programs. 
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APPENDICES 
Appendix A:  The Cost-Effectiveness Toolkit for Collegiate Recovery Programs. 
 The Cost-Effectiveness Toolkit for Collegiate Recovery Programs (“the Toolkit”) is 
available at <<URL forthcoming>> and is intended to allow advocates to calculate a specific 
ICER for their own institution as it currently operates, or to project an ICER for a proposed 
CRP not yet in operation. The Toolkit contains four tabs: User-Supplied Data, Base Model, 
Worksheet, and References. The User-Supplied Data tab is where advocates can enter their 
own real or proposed CRP parameters for either the societal perspective or institutional 
perspective model, or for both. The Base Model tab provides point estimates for the base 
case, an estimate of the parameter for a small CRP or a large CRP if applicable, and the range 
of variation for that parameter used in the Monte Carlo simulation. The Worksheet tab 
provides a worksheet for users to estimate the cost of tuition lost to substance-related 
attrition, adapted from the Everfi (n.d.) attrition calculator, as well as a worksheet to estimate 
opportunity costs related to substance use on campus. The references tab provides full 
bibliographic references for each of the point estimates and the estimates of the range of 
variation, where applicable.  
 The User-Supplied Data tab contains two workspaces: Model 1 – Societal Perspective 
(see Figure A1) and Model 2 – Institutional Perspective (Figure A2). Only cells highlighted 
in either yellow or blue may be modified by the user. In both the societal and institutional 
perspective model, the individual institution’s actual or proposed CRP budget, membership 
size, and relapse rate may be entered. Greater customization is available in Toolkit for the 
institutional perspective model: the substance-related attrition cost, opportunity cost, tuition, 
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enrollment size, and substance-related and general attrition costs can be customized in 
addition to the variables mentioned above. The ICER generated from the institution model 
calculation can then be considered highly customized to that specific institution’s parameters.  
 
Figure A1. Societal Perspective customizable model in The Cost-Effectiveness Toolkit for 
Collegiate Recovery Programs. 
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Figure A2. Institutional Perspective customizable model in The Cost-Effectiveness Toolkit 
for Collegiate Recovery Programs.  
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Appendix B. R code used for the Monte Carlo simulation. 
 
Monte Carlo for CEA of CRPs 
library("triangle",  
        lib.loc="/Library/Frameworks/R.framework/Versions/3.5/Resources/li
brary") 
library(sn) 
 
set.seed(123) 
Societal Perspective 
mc_societal_basecase<-data.frame( 
  cost_tau = c(rtriangle(n=10000,a=18415918781.73,b=27623878172.59,c=23019
898477.16)), 
  cost_pp = c(rtriangle(n=10000,a=17949.24,b=26923.86,c=22436.55)), 
  budget = c(rtriangle(10000,a=159399.47,b=223379.40 , c=191389.44)), 
  memb = c(rpois(10000,8:19)), 
  relapse = c(rtriangle(n=10000,a=0.75,b=1,c=0.92)), 
  qalys_added = c(rtriangle(n=10000,a=15.75185654,b=38.98432449,c=25.2)) 
) 
 
mcsoc<-mc_societal_basecase 
mcsoc$icost<-(mcsoc$cost_tau-((mcsoc$memb*mcsoc$relapse)*mcsoc$cost_pp)+mc
soc$budget)-mcsoc$cost_tau 
mcsoc$ieffect<-mcsoc$qalys_added 
mcsoc$icer<-mcsoc$icost/mcsoc$ieffect 
 
mcm<-mean(mcsoc$icer) 
print(mcm) 
#mean= -2990.941 
mcsd<-sd(mcsoc$icer) 
print(mcsd) 
#sd = 4192.469 
mcz<-1.96 
mcme<-(mcz*mcsd)/sqrt(10000) 
mccih<-mcm+mcme 
mccil<-mcm-mcme 
print(mccil)  
# -3073.113 
print(mccih) 
# -2908.769 
Institutional Perspective 
nat_stu_conduct_subs <-(56038+184681) 
nat_arr_subs <-(19423+19992) 
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oppcost_pp_cond <- c(rtriangle(n=10000,a=15.67,b=23.51,c=19.59)) 
oppcost_pp_couns <- c(rtriangle(n=10000,a=20.11,b=30.17,c=25.14)) 
oppcost_pp_arr <- c(rtriangle(n=10000,a=24.22,b=36.32,c=30.27)) 
budget <- c(rtriangle(10000,a=159399.47,b=223379.40 , c=191389.44)) 
memb <- c(rpois(10000,8:19)) 
relapse <- c(rtriangle(n=10000,a=0.75,b=1,c=0.92)) 
enrollment <- c(rtriangle(n=10000,a=2000,b=60000,c=31000)) 
tuition <- c(rtriangle(n=10000,a=5000,b=50000,c=26120)) 
gen_attrition <- c(rtriangle(n=10000,a=0.18525,b=0.30875,c=0.247)) 
subs_attrition <- c(rtriangle(n=10000,a=0.1,b=0.2,c=0.15)) 
 
mci_bc1<-data.frame( 
  attrition = c(tuition*(enrollment*gen_attrition*subs_attrition)), 
  attributable_to_school = c(enrollment/19900000) 
  ) 
 
mci_bc<-data.frame( 
  tot_oppcost_cond = c(nat_stu_conduct_subs*mci_bc1$attributable_to_school
*oppcost_pp_cond), 
  tot_oppcost_couns = c((((enrollment*0.1206)*5.53)*0.11)*oppcost_pp_couns
), 
  tot_oppcost_arr = c(nat_arr_subs*mci_bc1$attributable_to_school*oppcost_
pp_arr) 
) 
 
inst_mc<-data.frame( 
  tot_oppcost_cond = c(mci_bc$tot_oppcost_cond), 
  tot_oppcost_couns = c(mci_bc$tot_oppcost_couns), 
  tot_oppcost_arr = c(mci_bc$tot_oppcost_arr), 
  attrition = c(mci_bc1$attrition), 
  attrib = c(mci_bc1$attributable_to_school), 
  oppcost_pp_cond =c(oppcost_pp_cond), 
  oppcost_pp_couns = c(oppcost_pp_couns), 
  oppcost_pp_arr =c(oppcost_pp_arr), 
  budget =c(budget), 
  memb=c(memb), 
  relapse=c(relapse), 
  enrollment=c(enrollment), 
  tuition=c(tuition), 
  gen_attrition=c(gen_attrition), 
  subs_attrition=c(subs_attrition) 
) 
 
inst_mc$DoNothingCost<-(inst_mc$attrition+ 
                                inst_mc$tot_oppcost_arr+ 
                                inst_mc$tot_oppcost_couns+ 
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                                inst_mc$tot_oppcost_cond) 
inst_mc$CRPCost<-(inst_mc$DoNothingCost- 
                          (inst_mc$tuition* 
                             inst_mc$memb*inst_mc$relapse)- 
                          ((inst_mc$memb*inst_mc$relapse)* 
                             (inst_mc$oppcost_pp_cond+ 
                                inst_mc$oppcost_pp_arr+ 
                                inst_mc$oppcost_pp_couns))+ 
                          inst_mc$budget) 
 
inst_mc$icost<-inst_mc$CRPCost-inst_mc$DoNothingCost 
 
inst_mc$DoNothingEffect<-(inst_mc$enrollment*inst_mc$gen_attrition*inst_mc
$subs_attrition)- 
  (inst_mc$enrollment*inst_mc$gen_attrition*inst_mc$subs_attrition) 
 
inst_mc$CRPEffect<-round(( 
  inst_mc$enrollment*inst_mc$gen_attrition*inst_mc$subs_attrition)- 
  ((inst_mc$enrollment*inst_mc$gen_attrition*inst_mc$subs_attrition)- 
  (inst_mc$memb*inst_mc$relapse)),0) 
 
inst_mc$ieffect<-(inst_mc$CRPEffect-inst_mc$DoNothingEffect) 
 
inst_mc$ICER<-(inst_mc$icost/inst_mc$ieffect) 
 
mcm_inst<-mean(inst_mc$ICER) 
print(mcm_inst) 
#mean= -8196.281 
mcsd_inst<-sd(inst_mc$ICER) 
print(mcsd_inst) 
#sd = 13836.75 
mcz<-1.96 
mcme_inst<-(mcz*mcsd_inst)/sqrt(10000) 
mccih_inst<-mcm_inst+mcme_inst 
mccil_inst<-mcm_inst-mcme_inst 
print(mccil_inst)  
# -8467.481  
print(mccih_inst) 
# -7925.081 
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